Download presentation
Presentation is loading. Please wait.
Published byInge Johan Modified over 5 years ago
1
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma Tomer M. Mark, Danielle Guarneri, Peter Forsberg, Adriana Rossi, Roger Pearse, Arthur Perry, Karen Pekle, Linda Tegnestam, June Greenberg, Tsiporah Shore, Usama Gergis, Sebastian Mayer, Koen Van Besien, Scott Ely, David Jayabalan, Daniel Sherbenou, Morton Coleman, Ruben Niesvizky Biology of Blood and Marrow Transplantation Volume 23, Issue 6, Pages (June 2017) DOI: /j.bbmt Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions
2
Figure 1 Pre-ASCT conditioning regimen and post-ASCT maintenance therapy. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.